ESR1 and metastatic malignant neoplasm in the lymph nodes: When combining patients with an ERα-positive lymph node metastasis and/or primary tumor, we found significant lower OS (p = 0.012) and RFS (p = 0.0053) in the case of ERα positivity compared to ERα-negative patients (Figure 3).